(Q35537823)

8 August 2017

1 reference

title

Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time (English)

1 reference

hospital-acquired infection

8 August 2017

main subject

1 reference

1

Marin Kollef

1 reference

8 August 2017

publication date

1 January 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

63

1 reference

8 August 2017

issue

20

1 reference

8 August 2017

page(s)

2157-2168

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363200-00001

8 August 2017

exact match

0 references

cites work

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

1 reference

12 December 2020

Improving empiric antibiotic selection using computer decision support

1 reference

12 December 2020

Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

1 reference

12 December 2020

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

1 reference

12 December 2020

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

12 December 2020

Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system

1 reference

12 December 2020

Hospital-acquired pneumonia and de-escalation of antimicrobial treatment.

1 reference

12 December 2020

The role of understaffing in central venous catheter-associated bloodstream infections

1 reference

12 December 2020

Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices

1 reference

12 December 2020

A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

1 reference

12 December 2020

Appropriate use of antimicrobial agents: challenges and strategies for improvement

1 reference

12 December 2020

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

12 December 2020

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy

1 reference

12 December 2020

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

1 reference

12 December 2020

Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.

1 reference

12 December 2020

Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia

1 reference

12 December 2020

Quorum sensing and the regulation of virulence gene expression in pathogenic bacteria

1 reference

12 December 2020

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 reference

12 December 2020

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

12 December 2020

Clinical problems posed by multiresistant nonfermenting gram-negative pathogens.

1 reference

12 December 2020

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

12 December 2020

Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop

1 reference

12 December 2020

Antibiotic resistance in the intensive care unit

1 reference

12 December 2020

Health care--associated bloodstream infections: a change in thinking

1 reference

12 December 2020

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

12 December 2020

Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia

1 reference

12 December 2020

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

12 December 2020

Evidence-based guidelines for management of nursing home-acquired pneumonia

1 reference

12 December 2020

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

1 reference

12 December 2020

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

1 reference

12 December 2020

Nursing home-acquired pneumonia

1 reference

12 December 2020

Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome

1 reference

12 December 2020

Antimicrobial-drug resistance

1 reference

12 December 2020

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

1 reference

12 December 2020

Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

1 reference

12 December 2020

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

1 reference

12 December 2020

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

1 reference

12 December 2020

Is there a role for antibiotic cycling in the intensive care unit?

1 reference

12 December 2020

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study

1 reference

12 December 2020

Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices

1 reference

12 December 2020

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

12 December 2020

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

1 reference

12 December 2020

Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

1 reference

12 December 2020

Staphylococcus aureus resistant to vancomycin--United States, 2002.

1 reference

12 December 2020

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

1 reference

12 December 2020

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

1 reference

12 December 2020

Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections

1 reference

12 December 2020

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

12 December 2020

Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.

1 reference

12 December 2020

Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization

1 reference

12 December 2020

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

1 reference

12 December 2020

Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?

1 reference

12 December 2020

Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections

1 reference

12 December 2020

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

1 reference

12 December 2020

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

1 reference

12 December 2020

A computer-assisted management program for antibiotics and other antiinfective agents

1 reference

12 December 2020

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

1 reference

12 December 2020

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

1 reference

12 December 2020

Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies

1 reference

12 December 2020

10.2165/00003495-200363200-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

8 August 2017

1017599941

0 references

1 reference